These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier. Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA. Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683 [Abstract] [Full Text] [Related]
12. New approaches to mucosal immunization. Langermann S. Semin Gastrointest Dis; 1996 Jan 18; 7(1):12-8. PubMed ID: 8903575 [Abstract] [Full Text] [Related]
13. Oral vaccine delivery: can it protect against non-mucosal pathogens? Wang L, Coppel RL. Expert Rev Vaccines; 2008 Aug 18; 7(6):729-38. PubMed ID: 18665772 [Abstract] [Full Text] [Related]
14. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization. Verdonck F, Joensuu JJ, Stuyven E, De Meyer J, Muilu M, Pirhonen M, Goddeeris BM, Mast J, Niklander-Teeri V, Cox E. Vaccine; 2008 Oct 23; 26(45):5728-35. PubMed ID: 18762221 [Abstract] [Full Text] [Related]
15. Enteric vaccines. Edelman R, Levine MM. Md Med J; 1991 Mar 23; 40(3):199-203. PubMed ID: 2008164 [Abstract] [Full Text] [Related]
17. Development of oral vaccines for human use. Fooks AR. Curr Opin Mol Ther; 2000 Feb 23; 2(1):80-6. PubMed ID: 11249655 [Abstract] [Full Text] [Related]